콘텐츠로 건너뛰기
Merck
  • Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6.

Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6.

PLoS pathogens (2013-07-05)
Xing Liu, Wei Chen, Qiang Wang, Li Li, Chen Wang
초록

The signaling of Toll-like receptors (TLRs) induces host defense against microbial invasion. Protein posttranslational modifications dynamically shape the strength and duration of the signaling pathways. It is intriguing to explore whether de-SUMOylation could modulate the TLR signaling. Here we identified SUMO-specific protease 6 (SENP6) as an intrinsic attenuator of the TLR-triggered inflammation. Depletion of SENP6 significantly potentiated the NF-κB-mediated induction of the proinflammatory genes. Consistently, SENP6-knockdown mice were more susceptible to endotoxin-induced sepsis. Mechanistically, the small ubiquitin-like modifier 2/3 (SUMO-2/3) is conjugated onto the Lysine residue 277 of NF-κB essential modifier (NEMO/IKKγ), and this impairs the deubiquitinase CYLD to bind NEMO, thus strengthening the inhibitor of κB kinase (IKK) activation. SENP6 reverses this process by catalyzing the de-SUMOylation of NEMO. Our study highlights the essential function of the SENP family in dampening TLR signaling and inflammation.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Anti-SENP6 antibody produced in rabbit, affinity isolated antibody